Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
FormFactor
FORM
$10.3B
| $976K | ﹤0.01% |
139,400
-84
| -0.1% | -$638 |
|
|
HRC
2502
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $976K | ﹤0.01% |
19,532
+1,155
| +6% | +$54.5K |
|
2503
CorVel
CRVL
$3.23B
| $972K | ﹤0.01% |
74,691
+57,891
| +345% | +$814K |
|
2504
PUT
Golar LNG
GLNG
$5.24B
| $972K | ﹤0.01% |
57,200
+23,800
| +71% | +$406K |
|
2505
W.P. Carey
WPC
$16.3B
| $972K | ﹤0.01% |
16,014
+5,221
| +48% | +$297K |
|
2506
Calumet Specialty Products
CLMT
$4.29B
| $971K | ﹤0.01% |
88,279
-26,162
| -23% | -$364K |
|
2507
Ligand Pharmaceuticals
LGND
$5.71B
| $971K | ﹤0.01% |
14,539
+12,764
| +719% | +$776K |
|
|
CVSA
2508
Covista Inc
CVSA
$4.52B
| $969K | ﹤0.01% |
57,002
+26,043
| +84% | +$515K |
|
2509
Deutsche Bank
DB
$72.1B
| $968K | ﹤0.01% |
+67,763
| New | +$1.13M |
|
2510
CALL
Direxion Daily Energy Bear 2X ETF
ERY
$36.4M
| $968K | ﹤0.01% |
880
+240
| +38% | +$360K |
|
2511
CALL
A.O. Smith
AOS
$8.49B
| $965K | ﹤0.01% |
25,400
+10,000
| +65% | +$350K |
|
|
RDS.A
2512
CALL
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $960K | ﹤0.01% |
21,095
-50,628
| -71% | -$2.15M |
|
|
NTUS
2513
DELISTED
Natus Medical Inc
NTUS
| $959K | ﹤0.01% |
+25,221
| New | +$939K |
|
2514
Jefferies Financial Group
JEF
$12.9B
| $958K | ﹤0.01% |
66,879
-51,045
| -43% | -$718K |
|
2515
State Street SPDR S&P Bank ETF
KBE
$1.75B
| $957K | ﹤0.01% |
31,900
-45,502
| -59% | -$1.35M |
|
2516
Rambus
RMBS
$10.8B
| $957K | ﹤0.01% |
73,595
+73,568
| +272,474% | +$912K |
|
2517
CALL
Dick's Sporting Goods
DKS
$18.1B
| $952K | ﹤0.01% |
20,700
+6,400
| +45% | +$260K |
|
2518
PUT
Teck Resources
TECK
$31.2B
| $950K | ﹤0.01% |
135,700
-98,300
| -42% | -$532K |
|
2519
CALL
Entergy
ETR
$49.9B
| $948K | ﹤0.01% |
24,000
+18,000
| +300% | +$654K |
|
2520
ArcelorMittal
MT
$55.1B
| $947K | ﹤0.01% |
78,972
-5,533
| -7% | -$53.5K |
|
|
CVRR
2521
DELISTED
CVR Refining, LP
CVRR
| $944K | ﹤0.01% |
78,647
-57,471
| -42% | -$814K |
|
|
LMNX
2522
DELISTED
Luminex Corp
LMNX
| $943K | ﹤0.01% |
49,604
-29,246
| -37% | -$557K |
|
2523
Vince Holding Corp
VNCE
$78.8M
| $942K | ﹤0.01% |
15,700
-7
| -0% | -$392 |
|
|
SCLN
2524
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $939K | ﹤0.01% |
85,376
+60,822
| +248% | +$541K |
|
2525
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.32B
| $938K | ﹤0.01% |
9,200
-336,627
| -97% | -$33.6M |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.